Morphological and immunohistochemical identification of epithelial-to-mesenchymal transition in clinical prostate cancer
Kimberley Kolijn(Erasmus University Rotterdam), Geert J.L.H. van Leenders(Erasmus MC Cancer Institute)
Cited by 56
Related Papers
Molecular Grade (FGFR3/MIB-1) and EORTC Risk Scores Are Predictive in Primary Non–Muscle-Invasive Bladder Cancer
|European Urology|2010|193
FGFR3 Mutation Status and FGFR3 Expression in a Large Bladder Cancer Cohort Treated by Radical Cystectomy: Implications for Anti-FGFR3 Treatment?†
|European Urology|2020|89
Outcomes of a Bladder Cancer Screening Program Using Home Hematuria Testing and Molecular Markers
|European Urology|2013|58
Molecular and clinical support for a four-tiered grading system for bladder cancer based on the WHO 1973 and 2004 classifications
|Modern Pathology|2014|47
Prognostic markers in invasive bladder cancer: FGFR3 mutation status versus P53 and KI-67 expression: a multi-center, multi-laboratory analysis in 1058 radical cystectomy patients
|Urologic Oncology Seminars and Original Investigations|2021|39